Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Retatrutide is administered once a week via injection, potentially making it easier to integrate into a hectic lifestyle than daily pills or shots
As the bar for coverage and value of data heightens, opportunities emerge for solutions that enhance innovation within the obesity patient paradigm
Frequently Asked Questions Based on the current timeline, retatrutide FDA approval is expected between Q3 2027 (if priority review is granted) and Q1Q2 2028 (under standard review)
Copper balance: Extended daily injectable use accumulates copper over time
US$ 28.22
US$ 26.50
US$ 26.22
US$ 23.34
